CAR-T cell therapy

Aurigene Oncology gets DCGI nod for phase-2 trials of CAR-T cell therapy Ribrecabtagene autoleucel

2 min read

Business

Aurigene Oncology gets DCGI nod for phase-2 trials of CAR-T cell therapy Ribrecabtagene autoleucel

Daily News Express October 8, 2024

Aurigene Oncology lab (Picture credit: Aurigene Oncology Limited) HYDERABAD: Dr Reddy’s Laboratories‘wholly-owned subsidiary, Aurigene Oncology Limited, has...

CAR-T cell therapy

Aurigene Oncology gets DCGI nod for phase-2 trials of CAR-T cell therapy Ribrecabtagene autoleucel

You may have missed

Durgapur rape case: Don’t blame women for the violence they suffer

India’s growth pursuit: Lessons to learn from China’s story

The works of Krishnan Srinivasan: Mr Marco and Ms Deb, solving crimes in Kolkata

Stairway to enhancing social privilege, prestige